Insider Transactions in Q3 2024 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Gregory R Friberg EVP, Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,060
+35.66%
|
-
|
|
Sep 13
2024
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
12,098
-6.14%
|
$1,016,232
$84.9 P/Share
|
|
Aug 13
2024
|
Erin Burkhart GVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
714
-4.71%
|
$64,260
$90.0 P/Share
|